In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
NOACs in patients undergoing cardiac procedures
Session

Congress : ESC Congress 2019

Topic : Atrial Fibrillation

  • Session type : Satellite Symposium
  • Date : 02 September 2019
  • Time : 13:00 - 14:00
  • Sponsored by Boehringer Ingelheim

5 presentations in this session

From RE-LY to RE-DUAL PCI: a decade of innovation

Congress : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : C Cannon (Boston,US)
  • Sponsored by Boehringer Ingelheim

Antithrombotic therapy post-PCI: is your practice keeping up with the guidelines?

Congress : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : DJ Angiolillo (Jacksonville,US)
  • Sponsored by Boehringer Ingelheim

Antithrombotic therapy post-PCI: practical tips for challenging scenarios

Congress : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : J ten Berg (Nieuwegein,NL)
  • Sponsored by Boehringer Ingelheim

Cardioversion, ablation, and devices: practical tips to treat your atrial fibrillation patients

Congress : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : D Gupta (Liverpool,GB)
  • Sponsored by Boehringer Ingelheim

Panel discussion and questions and answers: NOACs in cardiac patients undergoing procedures

Congress : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : C Cannon (Boston,US), DJ Angiolillo (Jacksonville,US)
  • Sponsored by Boehringer Ingelheim

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are